Pfizer (NYSE: PFE) was a hot stock during the pandemic, but it has been crashing in recent years. The company's COVID vaccine ...

Despite ongoing concerns about overvalued stocks, many value investors sleep well at night. That’s because the key to ...

Activist Starboard Value, one of the first investors to publicly push Salesforce to make changes three years ago, increased ...

Indian stocks saw mild gains as investors awaited a crucial meeting between Trump and Putin. The Nifty 50 rose 0.05% to ...

Pfizer's stock rose 8.03%, despite bearish technicals and mixed analyst ratings. Technical indicators signal a bearish ...

At the same time, more than half of the US-listed stocks covered by Morningstar that reported earnings as of Aug. 11 beat ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. The FLOTILLA Study, officially titled ‘ENCORAFENIB/BINIMETINIB MASTER ...

I am reversing my rating on Akero Therapeutics stock from Buy to Sell due to valuation concerns and a long-ish wait for ...

Cash and equivalents (GAAP) totaled $13.1 million as of Q2 2025. These 10 stocks could mint the next wave of millionaires › Traws Pharma (NASDAQ:TRAW), a clinical-stage biopharmaceutical company ...

CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business UpdatesEntered into a definitive Purchase Agreement pursuant to which BioNTech intends to ...

Lawson, 76, remains proud of his time in office, saying he grew up poor in Gadsden County and wound up spending 28 years in ...

Legend Biotech announced its Q2 earnings, reporting $439m of revenues for its only commercial product, the cell therapy ...